SAB Biotherapeutics Inc • SABS

Capital at risk.

About SAB Biotherapeutics Inc
Ticker
info
SABS
Trading on
info
NASDAQ
ISIN
info
US78397T1034
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Samuel J. Reich
Headquarters
info
777 W 41st St., Miami Beach, FL, United States, 33140
Employees
info
63
Website
info
sabbiotherapeutics.com
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.
Metrics
BasicAdvanced
Market cap
info
$33.1M
P/E ratio
info
-
EPS
info
-$3.99
Dividend Yield
info
0.00%
Beta
info
0.61
Forward P/E ratio
info
0
EBIDTA
info
$-38.5M
Ex dividend date
info
-
Price & volume
Market cap
info
$33.1M
Average daily volume
info
0.3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
288.65
Price to book
info
1.74
Earnings
EPS
info
-$3.99
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-38.5M
Revenues (TTM)
info
$0.1M
Revenues per share (TTM)
info
$0.01
Technicals
Beta
info
0.61
52-week High
info
$5.01
52-week Low
info
$1.00
50-day moving average
info
$2.43
200-day moving average
info
$2.05
Short ratio
info
1.48
Short %
info
8.18%
Management effectiveness
ROE (TTM)
info
-127.48%
ROA (TTM)
info
-56.81%
Profit margin
info
0.00%
Gross profit margin
info
$-30M
Operating margin
info
-36,463.03%
Growth
Quarterly earnings growth (YoY)
info
-60.00%
Quarterly revenue growth (YoY)
info
-62.40%
Share stats
Outstanding Shares
info
10.4M
Float
info
1M
Insiders %
info
56.55%
Institutions %
info
80.57%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 5 analysts.

Average price target

info
$8.83
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$1.12
-$1.09
-2.75%
Q3 • 24Missed
-$0.98
-$1.21
18.93%
Q4 • 24Beat
-$0.56
-$1.07
47.79%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-5.2M
-∞%
Q1 • 25
$0M
$-10.1M
-∞%
Q2 • 25
NaN%
94.62%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$38.1M
$16.7M
43.84%
Q1 • 25
$30.1M
$18.1M
60.12%
Q2 • 25
-20.96%
8.38%
37.12%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-7.8M
$4.7M
$-0.2M
$-7.8M
Q1 • 25
$-7.2M
$5.2M
$-0.2M
$-14.5M
Q2 • 25
-8.28%
11.28%
-0.08%
85.76%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a SAB Biotherapeutics Inc share?
Collapse

SAB Biotherapeutics Inc shares are currently traded for undefined per share.

How many shares does SAB Biotherapeutics Inc have?
Collapse

SAB Biotherapeutics Inc currently has 10.4M shares.

Does SAB Biotherapeutics Inc pay dividends?
Collapse

No, SAB Biotherapeutics Inc doesn't pay dividends.

What is SAB Biotherapeutics Inc 52 week high?
Collapse

SAB Biotherapeutics Inc 52 week high is $5.01.

What is SAB Biotherapeutics Inc 52 week low?
Collapse

SAB Biotherapeutics Inc 52 week low is $1.00.

What is the 200-day moving average of SAB Biotherapeutics Inc?
Collapse

SAB Biotherapeutics Inc 200-day moving average is $2.05.

Who is SAB Biotherapeutics Inc CEO?
Collapse

The CEO of SAB Biotherapeutics Inc is Samuel J. Reich.

How many employees SAB Biotherapeutics Inc has?
Collapse

SAB Biotherapeutics Inc has 63 employees.

What is the market cap of SAB Biotherapeutics Inc?
Collapse

The market cap of SAB Biotherapeutics Inc is $33.1M.

What is the P/E of SAB Biotherapeutics Inc?
Collapse

The current P/E of SAB Biotherapeutics Inc is null.

What is the EPS of SAB Biotherapeutics Inc?
Collapse

The EPS of SAB Biotherapeutics Inc is -$3.99.

What is the PEG Ratio of SAB Biotherapeutics Inc?
Collapse

The PEG Ratio of SAB Biotherapeutics Inc is null.

What do analysts say about SAB Biotherapeutics Inc?
Collapse

According to the analysts SAB Biotherapeutics Inc is considered a buy.